Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
125 hedge funds and large institutions have $434M invested in Amedisys in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 21 closing their positions.
153% more call options, than puts
Call options by funds: $4.1M | Put options by funds: $1.62M
146% more capital inflows, than outflows
Capital inflows: $114M | Capital outflows: $46.3M
25% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 40
3.5% more ownership
Funds ownership: 87.09% → 90.59% (+3.5%)
4% less funds holding
Funds holding: 130 → 125 (-5)
19% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 21
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Kohlberg Kravis Roberts & Co
New York
|
+$77.9M |
| 2 |
North Tide Capital
Boston,
Massachusetts
|
+$7.25M |
| 3 |
Clough Capital Partners
Boston,
Massachusetts
|
+$4.39M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.84M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Teachers Advisors
New York
|
-$6.27M |
| 2 |
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$4.9M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$4.15M |
| 4 |
Oxford Asset Management
Oxford,
United Kingdom
|
-$3.8M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3.28M |
AMED Hedge Fund Activity: Q4 2013 in Review
125 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2013, worth a combined $434M — down 11% from $487M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of AMED and 17 opened new positions — a net loss of 4 holders — while 40 trimmed existing stakes and 50 added.
The largest buyer was Kohlberg Kravis Roberts & Co, opening a new position worth an estimated $77.9M. The largest seller was Teachers Advisors, cutting an estimated $6.27M.
- 125 institutional investors held Amedisys (AMED) as of Q4 2013, down from 130 in Q3 2013.
- Funds reported $434M of Amedisys stock for Q4 2013, down 11% quarter-over-quarter.
- 17 funds opened new Amedisys positions in Q4 2013 and 21 closed out, a net change of -4 holders.
- The largest Amedisys buyer in Q4 2013 was Kohlberg Kravis Roberts & Co, an estimated $77.9M added.
- The largest Amedisys seller in Q4 2013 was Teachers Advisors, an estimated $6.27M sold.
Based on aggregated 13F filings for Q4 2013.